logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo merck_oncology

FDA approves Aliqopa as 3rd-line therapy for relapsed FL

Copanlisib is a new TKI for patients failing ≥2 prior systemic therapies.